HomeKPTI • NASDAQ
Karyopharm Therapeutics Inc
add
$4.04
4.66%
Pre-market:(16.58%)+0.67
$4.71
Closed: Apr 8, 4:53:05 AM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 30.54M | -9.50% |
Operating expense | 170.42M | 0.58% |
Net income | -30.78M | 26.43% |
Net profit margin | -100.78 | 18.71% |
Earnings per share | -3.60 | 33.33% |
EBITDA | -31.20M | 17.31% |
Effective tax rate | 0.35% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 108.71M | -43.21% |
Total assets | 164.42M | -31.62% |
Total liabilities | 350.44M | -6.96% |
Total equity | -186.02M | — |
Shares outstanding | 8.42M | — |
Price to book | -0.17 | — |
Return on assets | -44.20% | — |
Return on capital | -82.27% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -30.78M | 26.43% |
Cash from operations | -25.81M | -38.88% |
Cash from investing | 14.80M | -44.88% |
Cash from financing | 680.00K | 157.58% |
Net change in cash | -10.35M | -220.23% |
Free cash flow | -7.17M | -209.50% |
Previous close
$3.86
Day range
$3.56 - $4.10
Year range
$3.51 - $21.30
Market cap
34.00M USD
Avg Volume
177.09K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2008
Headquarters
Website
Employees
279
